Literature DB >> 31548344

Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.

Sebastian R van der Voort1, Fatih Incekara2,3, Stefan Klein1, Marion Smits4, Maarten M J Wijnenga5, Georgios Kapas2, Mayke Gardeniers2, Joost W Schouten3, Martijn P A Starmans1, Rishie Nandoe Tewarie6, Geert J Lycklama7, Pim J French5, Hendrikus J Dubbink8, Martin J van den Bent5, Arnaud J P E Vincent3, Wiro J Niessen1,9.   

Abstract

PURPOSE: Patients with 1p/19q codeleted low-grade glioma (LGG) have longer overall survival and better treatment response than patients with 1p/19q intact tumors. Therefore, it is relevant to know the 1p/19q status. To investigate whether the 1p/19q status can be assessed prior to tumor resection, we developed a machine learning algorithm to predict the 1p/19q status of presumed LGG based on preoperative MRI. EXPERIMENTAL
DESIGN: Preoperative brain MR images from 284 patients who had undergone biopsy or resection of presumed LGG were used to train a support vector machine algorithm. The algorithm was trained on the basis of features extracted from post-contrast T1-weighted and T2-weighted MR images and on patients' age and sex. The performance of the algorithm compared with tissue diagnosis was assessed on an external validation dataset of MR images from 129 patients with LGG from The Cancer Imaging Archive (TCIA). Four clinical experts also predicted the 1p/19q status of the TCIA MR images.
RESULTS: The algorithm achieved an AUC of 0.72 in the external validation dataset. The algorithm had a higher predictive performance than the average of the neurosurgeons (AUC 0.52) but lower than that of the neuroradiologists (AUC of 0.81). There was a wide variability between clinical experts (AUC 0.45-0.83).
CONCLUSIONS: Our results suggest that our algorithm can noninvasively predict the 1p/19q status of presumed LGG with a performance that on average outperformed the oncological neurosurgeons. Evaluation on an independent dataset indicates that our algorithm is robust and generalizable. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31548344     DOI: 10.1158/1078-0432.CCR-19-1127

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  19 in total

1.  Non-invasive diagnosis of H3 K27M mutant midline glioma.

Authors:  Raymond Y Huang; Jeffrey P Guenette
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

2.  Deep learning approaches to non-invasively assess molecular features of gliomas.

Authors:  Rifaquat Rahman; Raymond Y Huang
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 12.300

3.  Pseudo-insular glioma syndrome: illustrative cases.

Authors:  Alexander F Haddad; Jacob S Young; Ramin A Morshed; S Andrew Josephson; Soonmee Cha; Mitchel S Berger
Journal:  J Neurosurg Case Lessons       Date:  2021-12-27

4.  Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.

Authors:  Julia Cluceru; Yannet Interian; Joanna J Phillips; Annette M Molinaro; Tracy L Luks; Paula Alcaide-Leon; Marram P Olson; Devika Nair; Marisa LaFontaine; Anny Shai; Pranathi Chunduru; Valentina Pedoia; Javier E Villanueva-Meyer; Susan M Chang; Janine M Lupo
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

5.  Probing individual-level structural atrophy in frontal glioma patients.

Authors:  Guobin Zhang; Xiaokang Zhang; Huawei Huang; Yonggang Wang; Haoyi Li; Yunyun Duan; Hongyan Chen; Yaou Liu; Bin Jing; Yanmei Tie; Song Lin
Journal:  Neurosurg Rev       Date:  2022-05-04       Impact factor: 2.800

6.  A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas.

Authors:  Chandan Ganesh Bangalore Yogananda; Bhavya R Shah; Frank F Yu; Marco C Pinho; Sahil S Nalawade; Gowtham K Murugesan; Benjamin C Wagner; Bruce Mickey; Toral R Patel; Baowei Fei; Ananth J Madhuranthakam; Joseph A Maldjian
Journal:  Neurooncol Adv       Date:  2020-07-17

Review 7.  MRI biomarkers in neuro-oncology.

Authors:  Marion Smits
Journal:  Nat Rev Neurol       Date:  2021-06-20       Impact factor: 42.937

8.  Medical Professional Enhancement Using Explainable Artificial Intelligence in Fetal Cardiac Ultrasound Screening.

Authors:  Akira Sakai; Masaaki Komatsu; Reina Komatsu; Ryu Matsuoka; Suguru Yasutomi; Ai Dozen; Kanto Shozu; Tatsuya Arakaki; Hidenori Machino; Ken Asada; Syuzo Kaneko; Akihiko Sekizawa; Ryuji Hamamoto
Journal:  Biomedicines       Date:  2022-02-25

9.  Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review.

Authors:  A P Bhandari; R Liong; J Koppen; S V Murthy; A Lasocki
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-26       Impact factor: 3.825

Review 10.  Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis.

Authors:  Evi J van Kempen; Max Post; Manoj Mannil; Benno Kusters; Mark Ter Laan; Frederick J A Meijer; Dylan J H A Henssen
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.